Clinical Trial Update: Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL [EARLY_Phase 1]

View source ↗

Summary

This update outlines an early-phase (Phase 1) clinical trial evaluating CD7 CAR-T therapy for newly diagnosed high-risk T lymphoblastic lymphoma and T-cell acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-lymphoblastic Lymphoma

Drugs mentioned

• CD7 CAR-T cell therapy

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: T Lymphoblastic Lymphoma, T Acute Lymphoblastic Leukemia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING